A5038228413- Chronic Obstructive Pulmonary Disease (COPD) Research
- Asthma and respiratory diseases
- Respiratory Support and Mechanisms
- Inhalation and Respiratory Drug Delivery
- Respiratory and Cough-Related Research
- Diverse Educational Innovations Studies
- Diverse Education Studies and Reforms
- Child Development and Digital Technology
- Education Systems and Policy
- Online and Blended Learning
- Teacher Education and Leadership Studies
- Diverse Approaches in Healthcare and Education Studies
- Palliative Care and End-of-Life Issues
- Sports, Gender, and Society
- Sports Analytics and Performance
- Physical Education and Pedagogy
- Library Science and Administration
- Global Educational Policies and Reforms
- Advanced Data Storage Technologies
- Parental Involvement in Education
- Nursing Diagnosis and Documentation
- Educational Assessment and Improvement
- School Choice and Performance
- Health Systems, Economic Evaluations, Quality of Life
- Global Education and Multiculturalism
University of Exeter
2014-2025
Royal Devon and Exeter Hospital
2014-2024
Observational & Pragmatic Research Institute
2019-2024
RELX Group (United States)
2024
Innovations for Poverty Action
2022
COPD Foundation
2021
Exeter Hospital
2005-2020
Colorado Kidney Care
2020
AstraZeneca (Brazil)
2020
Boehringer Ingelheim (Philippines)
2020
Section:ChooseTop of pageAbstract <<IntroductionDefinition and Factors Th...Diagnosis Initial Ass...Prevention Maintenanc...Rehabilitation, Education...Supportive, Palliative, E...Other TreatmentsInterventional TherapyManagement Stable COPDTreatment COPDMonitoring Follow-upTreatment OptionsCOPD ComorbiditiesReferencesCITING ARTICLES
The benefits of triple therapy for chronic obstructive pulmonary disease (COPD) with an inhaled glucocorticoid, a long-acting muscarinic antagonist (LAMA), and β2-agonist (LABA), as compared dual (either glucocorticoid–LABA or LAMA–LABA), are uncertain.
This Executive Summary of the Global Strategy for Diagnosis, Management, and Prevention COPD (GOLD) 2017 Report focuses primarily on revised novel parts document. The most significant changes include: 1) assessment chronic obstructive pulmonary disease has been refined to separate spirometric from symptom evaluation. ABCD groups are now proposed be derived exclusively patient symptoms their history exacerbations; 2) each A D, escalation strategies pharmacological treatments proposed; 3)...
<b>Executive summary of the Global Strategy for Prevention, Diagnosis and Management COPD 2023: latest evidence-based strategy document from Initiative Chronic Obstructive Lung Disease (GOLD</b><b>)</b> https://bit.ly/3KCaTGe
This Executive Summary of the Global Strategy for Diagnosis, Management and Prevention COPD, Initiative Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on revised novel parts document. The most significant changes include: (i) assessment chronic obstructive pulmonary disease has been refined to separate spirometric from symptom evaluation. ABCD groups are now proposed be derived exclusively patient symptoms their history exacerbations; (ii) each A D, escalation...
Rationale: The IMPACT (Informing the Pathway of Chronic Obstructive Pulmonary Disease Treatment) trial demonstrated a significant reduction in all-cause mortality (ACM) risk with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus UMEC/VI patients chronic obstructive pulmonary disease (COPD) at future exacerbations. Five hundred seventy-four were censored original analysis owing to incomplete vital status information.Objectives: Report ACM and impact stepping down therapy,...
Currently the diagnosis of chronic obstructive pulmonary disease (COPD) requires demonstration airflow limitation, defined as a post-bronchodilator FEV 1 /FVC <0.7, measurement that remains methodologically robust and widely available.FEV is one most powerful predictors clinically relevant outcomes including symptoms, exacerbations mortality.However, reliable data suggest respiratory in particular bronchitis, airway abnormality emphysema detected using modern imaging techniques such computed...